Joanne M. Bargman

11.8k total citations · 1 hit paper
266 papers, 7.2k citations indexed

About

Joanne M. Bargman is a scholar working on Nephrology, Surgery and Emergency Medical Services. According to data from OpenAlex, Joanne M. Bargman has authored 266 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 196 papers in Nephrology, 70 papers in Surgery and 62 papers in Emergency Medical Services. Recurrent topics in Joanne M. Bargman's work include Dialysis and Renal Disease Management (170 papers), Central Venous Catheters and Hemodialysis (62 papers) and Muscle and Compartmental Disorders (43 papers). Joanne M. Bargman is often cited by papers focused on Dialysis and Renal Disease Management (170 papers), Central Venous Catheters and Hemodialysis (62 papers) and Muscle and Compartmental Disorders (43 papers). Joanne M. Bargman collaborates with scholars based in Canada, United States and China. Joanne M. Bargman's co-authors include Dimitrios G. Oreopoulos, Kevin E. Thorpe, David Churchill, Stephen I. Vas, Jeffrey Perl, Sarbjit V. Jassal, Edward F. Vonesh, Sharon J. Nessim, Earl D. Silverman and Christopher T. Chan and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Joanne M. Bargman

253 papers receiving 6.9k citations

Hit Papers

Relative Contribution of ... 2001 2026 2009 2017 2001 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joanne M. Bargman Canada 42 5.5k 2.0k 1.6k 906 776 266 7.2k
Salim Mujais United States 40 3.8k 0.7× 1.4k 0.7× 1.4k 0.9× 889 1.0× 652 0.8× 121 5.8k
Peter G. Kerr Australia 53 6.2k 1.1× 1.4k 0.7× 1.6k 1.0× 1.7k 1.9× 550 0.7× 256 10.4k
Hugh C. Rayner United Kingdom 37 3.6k 0.7× 1.5k 0.8× 971 0.6× 1.1k 1.3× 586 0.8× 80 5.7k
David C. Mendelssohn Canada 44 4.9k 0.9× 1.5k 0.7× 687 0.4× 1.3k 1.4× 910 1.2× 98 7.4k
David Churchill Canada 44 3.5k 0.6× 1.4k 0.7× 1.5k 1.0× 1.5k 1.7× 689 0.9× 156 7.3k
Dimitrios G. Oreopoulos Canada 41 6.3k 1.1× 2.0k 1.0× 2.3k 1.5× 1.5k 1.7× 534 0.7× 391 8.7k
Rajnish Mehrotra United States 59 8.5k 1.6× 1.5k 0.8× 1.8k 1.2× 1.7k 1.9× 1.1k 1.5× 233 12.2k
Elisabeth W. Boeschoten Netherlands 43 5.1k 0.9× 1.5k 0.7× 1.2k 0.8× 727 0.8× 921 1.2× 91 6.2k
Kevan R. Polkinghorne Australia 45 5.1k 0.9× 1.7k 0.8× 1.2k 0.8× 1.7k 1.9× 570 0.7× 242 8.1k
Carmel M. Hawley Australia 53 6.1k 1.1× 2.3k 1.1× 2.4k 1.6× 1.8k 2.0× 777 1.0× 426 11.0k

Countries citing papers authored by Joanne M. Bargman

Since Specialization
Citations

This map shows the geographic impact of Joanne M. Bargman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joanne M. Bargman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joanne M. Bargman more than expected).

Fields of papers citing papers by Joanne M. Bargman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joanne M. Bargman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joanne M. Bargman. The network helps show where Joanne M. Bargman may publish in the future.

Co-authorship network of co-authors of Joanne M. Bargman

This figure shows the co-authorship network connecting the top 25 collaborators of Joanne M. Bargman. A scholar is included among the top collaborators of Joanne M. Bargman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joanne M. Bargman. Joanne M. Bargman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aflaki, Mona & Joanne M. Bargman. (2025). Urine Protein Tests in Systemic Lupus Erythematosus: What Do They Mean?. The Journal of Rheumatology. 52(4). jrheum.2024–910.
2.
Meyer, Timothy W. & Joanne M. Bargman. (2023). The Removal of Uremic Solutes by Peritoneal Dialysis. Journal of the American Society of Nephrology. 34(12). 1919–1927. 2 indexed citations
3.
Assimon, Magdalene M., Gary Cutter, & Joanne M. Bargman. (2022). The Non-Inferiority Complex: What Do Non-Inferiority Trials Tell Us?. Journal of the American Society of Nephrology. 33(4). 674–676.
4.
Yan, Hao, et al.. (2021). Incremental peritoneal dialysis in incident end-stage kidney disease patients. Peritoneal Dialysis International. 42(4). 387–393. 11 indexed citations
6.
Lightstone, Liz, et al.. (2017). Can we manage lupus nephritis without chronic corticosteroids administration?. Autoimmunity Reviews. 17(1). 4–10. 29 indexed citations
7.
Bose, Bhadran, Earl D. Silverman, & Joanne M. Bargman. (2013). Ten Common Mistakes in the Management of Lupus Nephritis. American Journal of Kidney Diseases. 63(4). 667–676. 25 indexed citations
8.
Li, Philip Kam‐Tao, Bruce F. Culleton, Jun-Young Do, et al.. (2013). Randomized, Controlled Trial of Glucose-Sparing Peritoneal Dialysis in Diabetic Patients. Journal of the American Society of Nephrology. 24(11). 1889–1900. 99 indexed citations
9.
Warnock, David G., Sudarshan Hebbar, Joanne M. Bargman, et al.. (2012). Prospective Safety Study of Bardoxolone Methyl in Patients with Type 2 Diabetes Mellitus, End-Stage Renal Disease and Peritoneal Dialysis. Contributions to nephrology. 178. 157–163. 4 indexed citations
10.
Nessim, Sharon J., Rosane Nisenbaum, Joanne M. Bargman, & Sarbjit V. Jassal. (2012). Microbiology of Peritonitis in Peritoneal Dialysis Patients with Multiple Episodes. Peritoneal Dialysis International. 32(3). 316–321. 26 indexed citations
11.
Perl, Jeffrey, Sharon J. Nessim, & Joanne M. Bargman. (2011). The biocompatibility of neutral pH, low-GDP peritoneal dialysis solutions: benefit at bench, bedside, or both?. Kidney International. 79(8). 814–824. 41 indexed citations
12.
Nessim, Sharon J., Jeffrey Perl, & Joanne M. Bargman. (2010). The renin–angiotensin–aldosterone system in peritoneal dialysis: is what is good for the kidney also good for the peritoneum?. Kidney International. 78(1). 23–28. 38 indexed citations
13.
Perl, Jeffrey & Joanne M. Bargman. (2009). The Importance of Residual Kidney Function for Patients on Dialysis: A Critical Review. American Journal of Kidney Diseases. 53(6). 1068–1081. 127 indexed citations
14.
Liakopoulos, Vassilios, Murali Krishnan, Ioannis Stefanidis, et al.. (2004). Improvement in uremic symptoms after increasing daily dialysate volume in patients on chronic peritoneal dialysis with declining renal function. International Urology and Nephrology. 36(3). 437–443. 20 indexed citations
15.
Sunder, S., Hülya Taşkapan, Murali Krishnan, et al.. (2004). Chronic peritoneal dialysis in the tenth decade of life. International Urology and Nephrology. 36(4). 605–609. 12 indexed citations
16.
McCormick, Brendan & Joanne M. Bargman. (2003). The implications of the ADEMEX study for the peritoneal dialysis prescription: the role of small solute clearance versus salt and water removal. Current Opinion in Nephrology & Hypertension. 12(6). 581–585. 9 indexed citations
17.
Stigant, Caroline & Joanne M. Bargman. (2002). Whatʼs new in peritoneal dialysis: biocompatibility and continuous flow peritoneal dialysis. Current Opinion in Nephrology & Hypertension. 11(6). 597–602. 9 indexed citations
18.
Finelli, Anthony, Imran Rasul, Jay Keystone, & Joanne M. Bargman. (1997). Development of severe secondary hypertension in a patient with systemic entomophthoromycosis. American Journal of Kidney Diseases. 29(4). 620–623. 6 indexed citations
19.
Vas, Stephen I., Joanne M. Bargman, & Dimitrios G. Oreopoulos. (1997). Treatment in Pd Patients of Peritonitis Caused by Gram-Positive Organisms with Single Daily Dose of Antibiotics. Peritoneal Dialysis International. 17(1). 91–92. 41 indexed citations
20.
Muirhead, Norman, Joanne M. Bargman, Ellen Burgess, et al.. (1995). Evidence-based recommendations for the clinical use of recombinant human erythropoietin. American Journal of Kidney Diseases. 26(2). S1–S24. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026